The YSI 2300 Analyzer Replacement Meeting Report.


Journal

Journal of diabetes science and technology
ISSN: 1932-2968
Titre abrégé: J Diabetes Sci Technol
Pays: United States
ID NLM: 101306166

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 17 3 2020
medline: 24 8 2021
entrez: 17 3 2020
Statut: ppublish

Résumé

This is a summary report of the most important aspects discussed during the YSI 2300 Analyzer Replacement Meeting. The aim is to provide the interested reader with an overview of the complex topic and propose solutions for the current issue. This solution should not only be adequate for the United States or Europe markets but also for all other countries. The meeting addendum presents three outcomes of the meeting.

Identifiants

pubmed: 32174135
doi: 10.1177/1932296820911471
pmc: PMC7576944
doi:

Substances chimiques

Biomarkers 0
Blood Glucose 0
Lactic Acid 33X04XA5AT

Types de publication

Congress Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

679-686

Références

J Diabetes Sci Technol. 2013 Nov 01;7(6):1585-94
pubmed: 24351185
J Diabetes Sci Technol. 2020 May;14(3):595-600
pubmed: 31711305

Auteurs

Julia Han (J)

Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.

Lutz Heinemann (L)

Profil Institut für Stoffwechselforschung GmbH, Neuss, Germany.

Barry H Ginsberg (BH)

American Diabetes Association, Arlington, VA, USA.

Shridhara Alva (S)

Abbott Diabetes Care, Alameda, CA, USA.

Matthias Appel (M)

Roche Diabetes Care, Mannheim, Germany.

Stephan Bess (S)

Radiometer/Danaher, Brea, CA, USA.

Kong Y Chen (KY)

National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.

Guido Freckmann (G)

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH, Ulm, Germany.

Dennis R Harris (DR)

Endocrine Society, Washington, DC, USA.

Matthias Hartwig (M)

Dr. Müller Gerätebau GmbH, Freital, Germany.

Rolf Hinzmann (R)

Roche Diabetes Care, Mannheim, Germany.

David Kerr (D)

Sansum Diabetes Research Institute, Santa Barbara, CA, USA.

Jan Krouwer (J)

Krouwer Consulting, Sherborn, MA, USA.

Linda Morrow (L)

ProSciento, Inc., Chula Vista, CA, USA.

James Nichols (J)

Vanderbilt University School of Medicine, Nashville, TN, USA.

Andreas Pfützner (A)

Pfützner Science & Health Institute, Mainz, Germany.

Stefan Pleus (S)

Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH, Ulm, Germany.

Mark Rice (M)

Vanderbilt University School of Medicine, Nashville, TN, USA.

David B Sacks (DB)

National Institutes of Health, Bethesda, MD, USA.

Kevin Schlueter (K)

YSI Life Sciences, Yellow Springs, OH, USA.

Hubert W Vesper (HW)

Centers for Disease Control and Prevention, Atlanta, GA, USA.

David C Klonoff (DC)

Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH